RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PASSARO A
Collezione AOU San Luigi di Orbassano

Items : 12

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2024 Oct 20;42(30):3593-3605. doi: 10.1200/JCO.24.01001. Epub 2024 Jun 10.

2024
AOU San Luigi di Orbassano

Leighl NB; Akamatsu H; Lim SM; Cheng Y; Minchom AR; Marmarelis ME; Sanborn RE; Chih-Hsin Yang J; Liu B; John T; Massutí B; Spira AI; Lee SH; Wang J; Li J; Liu C; Novello S; Kondo M; Tamiya M; Korbenfeld E; Moskovitz M; Han JY; Alexander M; Joshi R; Felip E; Voon PJ; Danchaivijitr P; Hsu PC; Silva Melo Cruz FJ; et alii...

Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 Nov;197:107990. doi: 10.1016/j.lungcan.2024.107990. Epub 2024 Oct 21.

2024
AOU San Luigi di Orbassano

Bertolaccini L; Tralongo AC; Del Re M; Facchinetti F; Ferrara R; Franchina T; Graziano P; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Cinquini M; Passiglia F; Novello S;

Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinib. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 Feb;194:104243. doi: 10.1016/j.critrevonc.2023.104243. Epub 2023 Dec 20

2024
AOU San Luigi di Orbassano

Russo GL; Bironzo P; Bennati C; Bonanno L; Catino A; Metro G; Petrini I; Russano M; Passaro A; Russo GL; Bironzo P; Bennati C; Bonanno L; Catino A; Metro G; Petrini I; Russano M; Passaro A;

Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jan;169:103536. doi: 10.1016/j.critrevonc.2021.103536. Epub 2021 Nov 18

2022
AOU San Luigi di Orbassano

Malapelle U; Pilotto S; Reale ML; Passiglia F; Pisapia P; Pepe F; Belluomini L; Galetta D; Cortinovis D; Tiseo M; Passaro A; Seminati D; Pagni F; Parra HS; Migliorino MR; Rocco D; Troncone G; Novello S; Malapelle U; Pilotto S; Reale ML; Passiglia F; Pisapia P; Pepe F; Belluomini L; Galetta D; Cortinovis D; Tiseo M; Passaro A; et alii...

Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP). in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2022 Dec;174:118-124. doi: 10.1016/j.lungcan.2022.11.005. Epub 2022 Nov 9.

2022
AOU San Luigi di Orbassano

Passaro A; Russo GL; Passiglia F; D'Arcangelo M; Sbrana A; Russano M; Bonanno L; Giusti R; Metro G; Bertolini F; Grisanti S; Carta A; Cecere F; Montrone M; Massa G; Perrone F; Simionato F; Guaitoli G; Scotti V; Genova C; Lugini A; Bonomi L; Attili I; de Marinis F;

Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features. in Cancers / Cancers (Basel). 2021 Jun 11;13(12):2935. doi: 10.3390/cancers13122935.

2021
AOU San Luigi di Orbassano

Passaro A; Novello S; Giannarelli D; Bria E; Galetta D; Gelibter A; Reale ML; Carnio S; Vita E; Stefani A; Pizzutilo P; Stati V; Attili I; de Marinis F;

Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2021 Feb;152:127-134. doi: 10.1016/j.lungcan.2020.12.011. Epub 2020 Dec 17.

2021
AOU San Luigi di Orbassano

de Marinis F; Laktionov KK; Poltoratskiy A; Egorova I; Hochmair M; Passaro A; Migliorino MR; Metro G; Gottfried M; Tsoi D; Ostoros G; Rizzato S; Mukhametshina GZ; Schumacher M; Novello S; Dziadziuszko R; Tang W; Clementi L; Cseh A; Kowalski D; de Marinis F; Laktionov KK; Poltoratskiy A; Egorova I; Hochmair M; Passaro A; Migliorino MR; Metro G; Gottfried M; et alii...

Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Aug 10;39(23):2574-2585. doi: 10.1200/JCO.20.02574. Epub 2021 Jun 2.

2021
AOU San Luigi di Orbassano

Ferrara R; Facchinetti F; Del Re M; Bertolaccini L; Cinquini M; Passiglia F; Franchina T; Larici AR; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Novello S;

Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102858. doi: 10.1016/j.critrevonc.2019.102858. Epub 2019 Dec 28

2020
AOU San Luigi di Orbassano

Rossi G; Ramella S; Passaro A; Menis J; Malapelle U; Franchina T; Ferrara R; Del Re M; Bertolaccini L; Facchinetti F; Pilotto S; Passiglia F; Trisolini R; Novello S;

Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings. in La Radiologia medica / Radiol Med. 2020 Feb;125(2):214-219. doi: 10.1007/s11547-019-01094-w. Epub 2019 Oct 11.

2020
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Scotti V; Piperno G; Filippi AR; Tindara F; Ferrari K; Chiari R; Bearz A; Passaro A; Trovò M; Vattemi E; Bezzi M; Comin C; Andolina M; Badellino S; Ramella S; Buffoni L; Genovesi D; Giaj-Levra N; Bruni A; Borghetti P; Franceschini D;

Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Apr;148:102862. doi: 10.1016/j.critrevonc.2019.102862. Epub 2020 Jan 25

2020
AOU San Luigi di Orbassano

Passiglia F; Bertolaccini L; Del Re M; Facchinetti F; Ferrara R; Franchina T; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Novello S;

Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer. in Future oncology (London, England) / Future Oncol. 2018 Feb;14(4):353-361. doi: 10.2217/fon-2017-0441. Epub 2017 Nov 14.

2018
AOU San Luigi di Orbassano

Metro G; Passaro A; Lo Russo G; Bonanno L; Giusti R; Gregorc V; Capelletto E; Martelli O; Cecere FL; Giannarelli D; Luciani A; Bearz A; Tuzi A; Scotti V; Tonini G; Galetta D; Carta A; Soto Parra H; Rebonato A; Morabito A; Chiari R; Metro G; Passaro A; Lo Russo G; Bonanno L; Giusti R; Gregorc V; Capelletto E; Martelli O; et alii...